LDLR and hyperlipidemia: Based on the beneficial effect of Fat-1 on hyperlipidemia and its key role in hepatic lipid metabolism in our 2 different hamster models, we further investigated whether AAV9-Fat-1 treatment could ameliorate atherosclerosis in WT and LDLR−/− hamsters.